| 2024 | 2023 | 2022 | 2021 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,5 M € | +17.2% | 4,7 M € | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||
| Gross margin | — | — | 3,0 M € | -4.7% | 3,1 M € | +80.7% | 1,7 M € | +8.4% | 1,6 M € | -7.2% | 1,7 M € | +20.4% | 1,4 M € | +34.6% | 1,1 M € | +1.6% | 1,1 M € | -2.0% | 1,1 M € | +44.0% | 744,3 k € | -5.4% | 786,9 k € | +34.8% | 583,6 k € | +2.9% | 567,1 k € | |||
| EBITDA | 2,5 M € | +12.8% | 2,2 M € | -13.9% | 2,6 M € | -6.7% | 2,8 M € | +147.7% | 1,1 M € | +8.1% | 1,0 M € | -11.9% | 1,2 M € | +9.5% | 1,1 M € | +37.1% | 787,0 k € | +1.8% | 772,9 k € | -6.3% | 824,9 k € | +64.8% | 500,6 k € | -22.3% | 644,6 k € | +49.5% | 431,2 k € | +10.7% | 389,6 k € | |
| Operating profit | 2,5 M € | +11.4% | 2,3 M € | -8.7% | 2,5 M € | -6.3% | 2,7 M € | +191.8% | 916,3 k € | +4.2% | 879,3 k € | -7.2% | 947,9 k € | +3.6% | 915,0 k € | +64.1% | 557,6 k € | -1.9% | 568,1 k € | -12.1% | 646,2 k € | +103.0% | 318,4 k € | -39.5% | 526,0 k € | +35.5% | 388,2 k € | +4.3% | 372,1 k € | |
| Profit/loss | 1,9 M € | +12.6% | 1,7 M € | -7.8% | 1,8 M € | -5.2% | 1,9 M € | +231.2% | 582,1 k € | -8.8% | 638,0 k € | -5.2% | 673,1 k € | +0.5% | 670,0 k € | +63.9% | 408,7 k € | +9.1% | 374,6 k € | -11.6% | 423,9 k € | +100.1% | 211,8 k € | -35.1% | 326,2 k € | +18.0% | 276,6 k € | +1.5% | 272,5 k € | |
| Equity | 3,5 M € | +119.6% | 1,6 M € | +88.9% | 840,0 k € | +3.4% | 812,5 k € | +1.0% | 804,2 k € | +0.3% | 802,1 k € | -76.8% | 3,5 M € | +24.2% | 2,8 M € | +6.5% | 2,6 M € | +18.6% | 2,2 M € | +20.5% | 1,8 M € | +30.2% | 1,4 M € | +17.8% | 1,2 M € | +37.7% | 864,4 k € | +47.0% | 587,9 k € | |
| Total assets | 4,1 M € | +82.2% | 2,3 M € | -43.4% | 4,0 M € | -11.3% | 4,5 M € | +123.2% | 2,0 M € | -32.7% | 3,0 M € | -23.0% | 3,9 M € | +12.6% | 3,4 M € | +14.9% | 3,0 M € | +22.6% | 2,4 M € | +13.3% | 2,2 M € | +29.2% | 1,7 M € | -6.9% | 1,8 M € | +26.5% | 1,4 M € | +24.5% | 1,1 M € | |
| Cash | 682,1 k € | +18.0% | 578,2 k € | -51.0% | 1,2 M € | -52.5% | 2,5 M € | +617.9% | 346,1 k € | -74.8% | 1,4 M € | +55.2% | 885,7 k € | +42.1% | 623,2 k € | +199.9% | 207,8 k € | -75.2% | 838,5 k € | +47.4% | 568,9 k € | — | 382,2 k € | -49.6% | 758,1 k € | +49.7% | 506,2 k € | |||
| Debts | 623,0 k € | -6.7% | 667,7 k € | -78.7% | 3,1 M € | -14.5% | 3,7 M € | +204.6% | 1,2 M € | -44.8% | 2,2 M € | +408.0% | 430,4 k € | -35.7% | 668,9 k € | +70.9% | 391,3 k € | +58.1% | 247,5 k € | -26.0% | 334,3 k € | +23.8% | 270,1 k € | -54.0% | 586,5 k € | +10.0% | 533,0 k € | -1.9% | 543,6 k € | |
| Staff | 4,8 | 4,9 | 5 | 5 | 7,8 | 7,3 | 5,9 | 6,4 | 4,6 | 4,3 | 3,8 | 3,7 | 2,6 | 2,4 | 2,6 | |||||||||||||||
Public limited company · Lommel · incorporated on 27/09/1972 · 4,8 ETP
Public limited company profitable and well capitalised. Cash position rising (+18.0%).
Solid counterparty for a standard engagement.
| Unit no. | Name | Location |
|---|---|---|
| 2039013541 | — | Rembert Dodoensstraat 51, 3920 Lommel |
GYNETICS MEDICAL PRODUCTS is a Public limited company incorporated in 1972. Its main activity is: Commerce de gros de produits pharmaceutiques et médicaux. Its registered office is in Lommel. It employs on average 4,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette